반려동물 보충제용 콘드로이틴 황산 시장 : 예측(2024-2029년)

The chondroitin sulfate for pet supplements market was valued at US$726.786 million in 2022.

Chondroitin sulfate, a natural compound present in cartilage, the protective tissue surrounding bones in joints, is a prevalent ingredient in pet supplements aimed at promoting joint health, particularly for dogs and cats grappling with osteoarthritis (OA). Pet owners often turn to daily joint supplements when addressing bone and joint diseases in their pets. These supplements, known as chondroprotective, also find use in mitigating inflammation in various bodily areas, particularly those exposed to fluids or mucus. For instance, pets with frequent urination due to an irritated bladder lining can benefit from formulations containing glucosamine and chondroitin.

Many pet owners prefer chondroprotective like glucosamine and chondroitin due to their holistic approach, promoting overall pet well-being rather than merely alleviating symptoms. Additionally, these supplements tend to have few side effects and enable pets to rely less on prescription medications. Importantly, chondroprotective supplements are generally considered safe for long-term use, potentially for a pet's lifespan. It is advisable to administer chondroitin supplements in response to joint injuries, initiating joint supplements early in a pet's life is also recommended as a preventive measure.

Market Drivers

• Rise in Pet Ownership

Worldwide, there is a growing trend of integrating pets into changing lifestyles, with pets becoming integral companions across the globe. The COVID-19 pandemic witnessed an upswing in pet adoption, notably in the United States, where the percentage of households with at least one dog increased from 38% to 45% between 2016 and 2020, and cat ownership experienced a steady rise from 25% to 29% in 2022. In China, 74 million households own dogs, the United States has 85 million dog owners, and the European Union boasts 92 million dog owners. These figures underscore the global significance of pets and their impact on the chondroitin sulfate market.

• Growing awareness of the significance of chondroitin sulfate

Chondroitin sulfate is gaining popularity in the pet supplement sector as awareness grows regarding its potential advantages for enhancing joint health in dogs and cats. Faced with concerns about possible side effects, pet owners are increasingly inclined toward natural methods to address their pet's well-being. Chondroitin sulfate, sourced from natural origins such as cartilage and shellfish, aligns with this preference, presenting a potentially safer alternative. Pet caregivers are becoming increasingly cognizant of the adverse impact of osteoarthritis (OA) on their pets' quality of life.

Market Challenges

• Regulatory challenges posing a hurdle

Navigating regulatory challenges poses an obstacle in the realm of pet supplements. At present, AAFCO exclusively oversees the labelling of supplements categorized as "food-type". Despite a growing body of scientific information on veterinary pet supplements and nutraceuticals, there persists a scarcity of quality control, safety, and efficacy data for the majority of these marketed substances and the corresponding products available for purchase. Despite this evidence gap, the utilization of veterinary supplements and nutraceuticals is on the rise. It is imperative for veterinarians and pet owners alike to advocate for enhanced enforcement of regulations governing these products and to call for manufacturers to collaborate more closely with researchers for the betterment of pets as well as the market.

By pet type, chondroitin sulfate for the pet supplements market is divided into dogs and cats

The chondroitin sulfate for the pet supplement market is segmented into two categories, i.e, dogs and cats- In the United States, 65.1 million households consider dogs integral family members. The feline companionship is also cherished, as revealed by the 46.5 million households that own a cat, according to the American Pet Products Association (APPA). Notably, the APPA highlights that a significant portion of pet owners in the U.S. are millennials, underscoring the growing importance of pets in the lives of this demographic.

Europe is anticipated to hold a notable share of the chondroitin sulfate for pet supplements

Europe is projected to account for a notable share of the chondroitin sulfate for pet supplements owing to the people's huge ownership of pets in these regions. As the FEDIAF Facts & Figures states the expanding landscape of pet ownership in Europe, indicates that 90 million households in the European Union have embraced the companionship of a pet, representing 46% of households. The breakdown of this pet population reveals approximately 110 million cats, 90 million dogs, 50 million birds, 30 million small mammals, 15 million aquariums, and 10 million terrariums, showcasing the diverse array of pets that contribute to the rich tapestry of European households.

Company Products

• Chondroitin sulfate - Unibridge's Chondroitin sulfate plays a vital role in diverse applications, including its use in pet food as a supplement. Specifically formulated for pets, Chondroitin sulfate is commonly employed to alleviate discomfort associated with osteoarthritis. Additionally, it contributes to the promotion of healthy bladder functions. Packaged in convenient 25kg drums, this product is well-suited for various needs.
• Chondroitin Sulfate - Shandong Haiyu Biological Co., Ltd. manufactures Chondroitin Sulfate (CS), an acid mucopolysaccharide sourced from animal tissues. Presented as a white or white-like powder without any discernible odor, it displays moisture-absorbing characteristics. Its primary medical application lies in the treatment of joint diseases, offering pain relief and supporting cartilage regeneration to address joint problems at a fundamental level. This versatile product finds various applications, including its incorporation into pet food as a supplementary additive, catering to the specific needs of pet dogs.
• CSbioactive® - CSbioactive® represents Bioiberica's scientifically validated chondroitin sulfate, well-known for its promotion of joint health. Acknowledged and employed worldwide as a benchmark component, CSbioactive® is supported by an extensive body of scientific research. This product is designed for business-to-business applications, serving as a key ingredient for pet supplements.

Market Segmentation

By Purity Level

• 99% Level
• Others

By Pet Type

• Cat
• Dog

By Geography

• North America
• USA
• Others
• Europe, Middle East, And Africa
• UK
• Germany
• France
• Others
• Asia Pacific
• China
• Japan
• South Korea
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Research Process

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. CHONDROITIN SULFATE FOR PET SUPPLEMENTS MARKET BY PURITY LEVEL

• 5.1. Introduction
• 5.2. 99% level
• 5.3. Others

6. CHONDROITIN SULFATE FOR PET SUPPLEMENTS MARKET BY PET TYPE

• 6.1. Introduction
• 6.2. Dogs
• 6.3. Cats

7. CHONDROITIN SULFATE FOR PET SUPPLEMENTS FEED MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. Americas
  • 7.2.1. USA
  • 7.2.2. Others
• 7.3. Europe, Middle East and Africa
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. UK
  • 7.3.4. Others
• 7.4. Asia Pacific
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
  • 7.4.4. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Mergers, Acquisitions, Agreements, and Collaborations

9. COMPANY PROFILES

• 9.1. Unibridge
• 9.2. Shandong Haiyu Biological Co., Ltd
• 9.3. ZPD A/S
• 9.4. Shandong Runxin Biotechnology Co., Ltd
• 9.5. Bioiberica S.A.U.

Not an exhaustive list